Currently predicting for Mon, 14 Jul 2025

Trading levels for AGIO

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis Powered by GPT-4o*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 40.33 3.29%
R2 39.88 2.12%
R1 39.59 1.40%
Price 39.05
S1 38.68 -0.94%
S2 38.40 -1.66%
S3 37.94 -2.83%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 39.53 1.23%
R1 39.07 0.0512%
Price 39.05
S1 34.41 -11.88%
S2 32.63 -16.44%
S3 31.84 -18.46%

AGIO Predictions History

2 years ago
JS predicted that AGIO for 2023-06-08 is going $26.86 (0.98%)

2 years ago
PredictionBot.Kathy predicted that AGIO for 2023-06-08 is going $26.64 (0.13%)

2 years ago
PredictionBot.Warren predicted that AGIO for 2023-06-08 is going $26.78 (0.69%)

6 years ago
NameNotImportant predicted that AGIO for 2019-04-29 is going $56.29 (-1.42%)

8 years ago
IM2Here predicted that AGIO for 2017-01-10 is going $38.00 (-11.17%)

Rank:
Click to get the best stock tips daily for free!
ABOUT AGIOS PHARMACEUTICALS
Agios Pharmaceuticals
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph...
GOLDEN STAR
Ticker Change Signal Date
RYTM
$62.29
39.19% Jun 25
NOV
$12.25
11.67% Jun 04
TENB
$32.20
1.13% Jun 02
G
GTM
$9.57
6.58% Jun 02
TAC
$8.90
28.20% May 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE